Cryo Health: the cryosauna for cryotherapy in medical applications

Cryo Health ontwikkelde de cryosauna

Aim

Cryosauna Nederland B.V., in collaboration with Zest B.V., aims to develop an innovative Cryosauna 2.0.

With this sauna cryotherapy:

  • the temperature can be precisely controlled over the entire cabin
  • the temperature can be adjusted to each individual body
  • the treatment can take place without the risk of burns

What is cryotherapy?

Cryotherapy is a cooling technique in which the entire body, from the bottom to the top of the shoulders, is exposed to very low temperatures (-110 ° C to -196 ° C) for a short time. This is done with the help of a cryosauna, a cabin that is cooled by liquid nitrogen. The treatment quickly cools the skin surface to around -1 ° C for a short period. This causes various physical reactions that have a positive influence on the blood circulation as well as metabolic processes, resulting in the recovery of muscles, a strengthened immune system, and pain relief.

Application

The effect of cryotherapy has been scientifically investigated and proven. However, proven technology to apply cryotherapy completely safe and attuned to the individual body is missing. As a result, cryotherapy is not yet included in the Dutch health insurance package. Application of cryotherapy to, for example, patients with rheumatism, is therefore not yet possible. The new cryosauna 2.0 is expected to have major impacts on this group of patients in terms of well-being and cost savings in healthcare. Cryotherapy can be applied by physiotherapists and having 7,700 physiotherapy practices in the Netherlands, the market for cryosaunas is substantial.

In addition to the (technical) development of the cryosauna 2.0, scientific and applied research will be conducted to determine the effects of cryotherapy, in particular on patients with rheumatism.

In addition to technological development, scientific and practical research will be conducted into the effects of cryotherapy, in particular on patients with rheumatism. As a result, more insights are gained in application possibilities, which are necessary to encourage insurance companies to include cryotherapy in the supplementary and even basic insurance package. The proposed development of the cryosauna 2.0 is essential to make this happen.

Consortium

  • Cryosauna Nederland B.V.
  • Zest B.V.
  • UMCU

Grant

MIT R&D partnership

 

Share this article via: LinkedIn | Twitter | Facebook